As a young, dynamic and creative molecular diagnostics company, we have specialized in simple and rapid solutions for the diagnosis of severe infectious diseases in hospitalized patients. We help to combat infections effectively and detect antibiotic resistance at an early stage.
Curetis’ Global Installed Base Expanding to Over 150 Unyvero Analyzers
Curetis Files for U.S. FDA Clearance for Unyvero Platform and LRT Application Cartridge
27. Symposium Intensivmedizin + Intensivpflege - Bremen, Germany - 15 to 17 February, 2017
TKR 2017 - Infected total knee replacement symposium - Manchester, United Kingdom - 23 to 24 February 2017